Fingerprint
Dive into the research topics of 'Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma
Thomas E. Witzig, Susan M. Geyer, Irene Ghobrial, David J. Inwards, Rafael Fonseca, Paul Kurtin, Stephen M. Ansell, Ronnie Luyun, Patrick J. Flynn, Roscoe F. Morton, Shaker R. Dakhil, Howard Gross, Scott H. Kaufmann
Research output: Contribution to journal › Article › peer-review
456
Scopus
citations